Adjuvant radiotherapy in male breast cancer

Radiotherapy and Oncology

Volumn 53, Issue 1, 1999, Pages 29-35

  Stranzl, Heidi ^a   Mayer, Ramona ^a   Quehenberger, Franz ^a   Prettenhofer, Ulrike ^a   Willfurth, Peter ^a   Stöger, Herbert ^a   Hackl, Arnulf ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Male breast cancer; Prognostic factor; Radiotherapy; Survival

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CLINICAL ARTICLE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0032734845     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00122-X     Document Type: Article

References (26)

1. Arriagada R., Rutqvist L.E., Mattsson A., Kramar A., Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J. Clin. Oncol. 13:(12):1995;2869-2878.
2. Bezwoda W.R., Hesdorffer C., Dansey R., et al. Breast cancer in men. Clinical features, hormone receptor status and response to therapy. Cancer. 60:(6):1987;1337-1340.
3. Borgen P.I., Wong G.Y., Vlamis V., et al. Current management of male breast cancer: a review of 104 cases. Ann. Surg. 215:(5):1992;451-459.
4. Demeter J.G., Waterman N.G., Verdi G.D. Familial male breast carcinoma. Cancer. 65:(10):1990;2342-2343.
5. Donegan W.L., Redlich P.N. Breast cancer in men. Surg. Clin. North. Am. 76:(2):1996;343-363.
6. Donegan W.L., Redlich P.N., Lang P.J., Gall M.T. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 83:(3):1998;498-509.
7. Erlichman C., Murphy K.C., Elhakim T. Male breast cancer: a 13-year review of 89 patients. J. Clin. Oncol. 2:(8):1984;903-909.
8. Evans D.B., Crichlow R.W. Carcinoma of the male breast and Klinefelter's Syndrome: is there an association? Can. Cancer J. Clin. 37:(4):1987;246-251.
9. Gough D.B., Donohue J.H., Evans M.M., et al. A 50-year experience of male breast cancer: is outcome changing? Surg. Oncol. 2:(6):1993;325-333.
10. Guinee V.F., Olsson H., Moller T., et al. The prognosis of breast cancer in males. Cancer. 71:(1):1993;154-161.
11. Hermanek P., Hutter R.V.P., Sobin L.H., et al. TNM Classification of malignant tumours UICC, International Union against Cancer. fourth ed :1992;Springer, New York. 2nd revision.
12. Holland R., Veling S.H.J., Mravunac M., Hendriks J.H.C.L. Histologic multifocality of Tis. T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 56:1985;979-990.
13. Holland R., Hendriks J.H.C.L., Veebek A.L., Mravunac M., Schuurmans-Stekhoven J.H. Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet. 335:(8688):1990;519-522.
14. Hultborn R., Friberg S., Hultborn K.A., Peterson L.E., Ragnhult I. Male breast carcinoma. II. A study of the total material reported to the Swedish cancer Registry 1958-1967 with respect to treatment, prognostic factors and survival. Acta Oncol. 26:(5):1987;327-341.
15. Joshi M.G., Lee A.K.C., Loda M., et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 77:(3):1996;490-498.
16. Michaels B.M., Nunn C.R., Roses D.F. Lobular carcinoma of the male breast. Surgery. 115:(3):1994;402-405.
17. Morimoto T., Komaki T., Yamakawa T., et al. Cancer of the male breast. J. Surg. Oncol. 44:(3):1990;180-184.
18. Neugut A.I., Murray T.I., Lee W.C., Robinson E. The association of breast cancer and colorectal cancer in men. Cancer. 68:(9):1991;2069-2073.
19. Olsson H., Andersson H., Johansson O., Moller T.R., Kristoffersson U., Wenngren E. Population-based cohort investigations of the risk for malignant tumours in first-degree relatives and wives of men with breast cancer. Cancer. 71:(4):1993;1273-1278.
20. Patel H.Z., Buzdar A.U., Hortobagyi G.N. Role of adjuvant chemotherapy in male breast cancer. Cancer. 64:(8):1989;1583-1585.
21. Rudan I., Rudan N., Basic N., Basic V., Rudan D. Differences between male and female breast cancer. II. Clinicopathologic features. Acta Med. Croatica. 51:(3):1997;129-133.
22. Rutqvist L.E., Pettersson D., Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomized clinical trial. Radiother. Oncol. 26:(2):1993;104-110.
23. Schuchardt U., Seegenschmiedt M.H., Kirschner M.J., Renner H., Sauer R. Adjuvant radiotherapy for breast carcinoma in men. A 20-year clinical experience. Am. J. Clin. Oncol. 19:(4):1996;330-336.
24. Thomas D.B., Rosenblatt K., Jimenez L.M., et al. Ionizing radiation and breast cancer in men (United States). Cancer Causes Control. 5:(1):1994;9-14.
25. Veronesi U., Rilke F., Luini A., et al. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer. 59:(4):1987;682-687.
26. Willsher P.C., Leach I.H., Ellis I.O., et al. Male breast cancer: pathological and immunohistochemical features. Anticancer Res. 17:(3C):1997;2335-2338.